7.5 Endnotes Tuhinga āpiti
1. Seth Berkley, ‘COVAX Explained’, Vaccines Work, Global Alliance for Vaccines and Immunization (Gavi) (3 September 2020), https://www.gavi.org/vaccineswork/covax-explained, accessed 3 July 2024.
2. Cabinet Paper, COVID-19 Vaccine Strategy, 2020, https://www.covid19.govt.nz/assets/Proactive-Releases/proactive-release-2020-june/PAPER-COVID-19-Vaccine-Strategy.pdf
3. Cabinet Paper, COVID-19 Vaccine Strategy, 2020, https://www.covid19.govt.nz/assets/Proactive-Releases/proactive-release-2020-june/PAPER-COVID-19-Vaccine-Strategy.pdf
4. Ministry of Business, Innovation and Employment, New Zealand Foreign Affairs and Trade, and Ministry of Health, Briefing: COVID-19 Vaccine Strategy – Early Progress, MBIE: 3859 19-20, 2 July 2020, pp 7-8, https://covid19.govt.nz/assets/Proactive-Releases/proactive-release-2020-october/HR41-Briefing-COVID-19-vaccine-strategy-early-progress.pdf
5. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), pp 18-19, https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
6. Cabinet Paper, COVID-19 Vaccine Strategy, 2020, https://www.covid19.govt.nz/assets/Proactive-Releases/proactive-release-2020-june/PAPER-COVID-19-Vaccine-Strategy.pdf
7. Ministry of Business, Innovation and Employment, New Zealand Foreign Affairs and Trade, and Ministry of Health, Briefing: COVID-19 Vaccine Strategy – Purchasing Strategy and funding envelope, MBIE: 2021-0139, 10 July 2020, https://covid19.govt.nz/assets/Proactive-Releases/proactive-release-2020-october/HR28-2021-0139-COVID-19-Vaccine-Strategy-Purchasing-Strategy-and-funding-en....pdf
8. Ministry of Business, Innovation and Employment, New Zealand Foreign Affairs and Trade, and Ministry of Health, Briefing: COVID-19 Vaccine Strategy – Purchasing Strategy and funding envelope, MBIE: 2021-0139, 10 July 2020, https://covid19.govt.nz/assets/Proactive-Releases/proactive-release-2020-october/HR28-2021-0139-COVID-19-Vaccine-Strategy-Purchasing-Strategy-and-funding-en....pdf
9. Ministry of Business, Innovation and Employment, New Zealand Foreign Affairs and Trade, and Ministry of Health, Briefing: COVID-19 Vaccine Strategy – Early Progress, MBIE: 3859 19-20, 2 July 2020, pp 6-7, https://covid19.govt.nz/assets/Proactive-Releases/proactive-release-2020-october/HR41-Briefing-COVID-19-vaccine-strategy-early-progress.pdf
10. Cabinet Paper, Update on the COVID-19 Immunisation Strategy and Programme, 7 December 2020, pp 1-2, https://www.health.govt.nz/system/files/2021-05/update_on_the_covid-19_immunisation_strategy_and_programme_december_2020.pdf
11. McGuinness Institute, COVID-19 Nation Dates (1st ed.) (Wellington, 2023), p 26, https://nationdatesnz.org/covid-19-nation-dates-1stedition
12. McGuinness Institute, COVID-19 Nation Dates (1st ed.) (Wellington, 2023), p 75, https://nationdatesnz.org/covid-19-nation-dates-1stedition
13. Ministry of Health, Briefing: COVID-19 Vaccine and immunisation update for joint Ministers, 20210037, obtained under Official Information Act 1982 request to Ministry of Health, 15 January 2021, https://www.health.govt.nz/system/files/2021-04/h202100194_h202100195_covid-19_vaccine_rollout_0.pdf
14. Steven Hamilton and Richard Holden, ‘The medical regulatory complex has failed us’, Australian Financial Review, 10 August 2021, https://www.afr.com/policy/health-and-education/on-covid-19-the-medical-regulatory-complex-has-failed-us-20210809-p58haw
15. Medsafe, ‘Summary of Recommendations from the 109th Meeting of the Medicines Assessment Advisory Committee held in Wellington on Tuesday 2 February 2021 at 9:30 AM’, updated 10 February 2022, https://www.medsafe.govt.nz/committees/maac/Recommendation109-2February2021.htm
16. Medsafe, ‘COVID-19 Vaccine Safety Monitoring Process’, updated 6 June 2024, https://www.medsafe.govt.nz/COVID-19/monitoring-process.asp
Medsafe, ‘Approval status of COVID-19 vaccine applications received by Medsafe’, updated 9 June 2024, https://www.medsafe.govt.nz/COVID-19/status-of-applications.asp
17. Carolina Graña, Lina Ghosn, Theodoros Evrenoglou, Alexander Jarde, Silvia Minozzi, Hanna Bergman, Brian S Buckley, Katrin Probyn, Gemma Villanueva, Nicholas Henschke, Hillary Bonnet, Rouba Assi, Sonia Menon, Melanie Marti, Declan Devane, Patrick Mallon, Jean-Daniel Lelievre, Lisa M Askie, Tamara Kredo, Gabriel Ferrand, Mauricia Davidson, Carolina Riveros, David Tovey, Joerg J Meerpohl, Giacomo Grasselli, Gabriel Rada, Asbjørn Hróbjartsson, Philippe Ravaud, Anna Chaimani, and Isabelle Boutron, ‘Efficacy and safety of COVID-19 vaccines’, Cochrane Database of Systematic Reviews, no. 12 (7 December 2022), https://doi.org/10.1002/14651858.CD015477, https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015477/full
World Health Organization, ‘The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need to know’, updated 18 August 2022, https://www.who.int/news-room/feature-stories/detail/who-can-take-the-pfizer-biontech-covid-19--vaccine-what-you-need-to-know
World Health Organization, Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing (first issued on 8 January 2021, last updated on 18 August 2022), https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-BNT162b2-2021.1
18. World Health Organization, ‘COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS): updated statement regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines’, updated 27 October 2021, https://www.who.int/news/item/27-10-2021-gacvs-statement-myocarditis-pericarditis-covid-19-mrna-vaccines-updated
19. World Health Organization, ‘COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS): updated statement regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines’, updated 27 October 2021, https://www.who.int/news/item/27-10-2021-gacvs-statement-myocarditis-pericarditis-covid-19-mrna-vaccines-updated
20. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), p 64, https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
21. Ministry of Business, Innovation and Employment, Department of the Prime Minister and Cabinet, Ministry of Health, New Zealand Customs Service, Border Executive Board, and New Zealand Foreign Affairs and Trade, COVID-19 Response Weekly Report (20 August 2021), https://www.dpmc.govt.nz/sites/default/files/2023-01/COVID-19-Response-Weekly-Report-20-August-2021.pdf
22. COVID-19 Vaccine Technical Advisory Group, Memo: Extending age groups who can receive COVID-19 vaccine, 13 August 2021, https://www.tewhatuora.govt.nz/assets/About-us/Who-we-are/Expert-groups/COVID-19-Vaccine-Technical-Advisory-Group-CV-TAG/Extending-age-groups-who-can-receive-COVID-19-vaccine.pdf
23. Ministry of Health, ‘90% of eligible population fully vaccinated; 91 community cases; 58 in hospital; 4 in ICU’, media release, 16 December 2021, https://www.health.govt.nz/news/90-of-eligible-population-fully-vaccinated-91-community-cases-58-in-hospital-4-in-icu
24. COVID-19 Vaccine Technical Advisory Group, Memo: Priority groups for COVID-19 booster vaccinations: COVID-19 Vaccine Technical Advisory Group (CV TAG) recommendations, 10 November 2021, https://www.tewhatuora.govt.nz/assets/About-us/Who-we-are/Expert-groups/COVID-19-Vaccine-Technical-Advisory-Group-CV-TAG/Recommendations-to-provide-a-booster-vaccination.pdf
25. Cabinet Paper, Decision to proceed with a booster programme for the COVID-19 Vaccine and Immunisation Programme, https://www.health.govt.nz/system/files/2022-05/decision_to_proceed_with_a_booster_programme_for_the_covid-19_vaccine_and_immunisation_programme.pdf
26. Hon Chris Hipkins, ‘Boosters and increased mask-use to prepare for Omicron’, media release, 4 February 2022, https://www.beehive.govt.nz/release/boosters-and-increased-mask-use-prepare-omicron
27. Julia R. Spinardi and Amit Srivastava, ‘Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines’, Biomedicines 11, no. 2 (27 January 2023), 370, https://doi.org/10.3390/biomedicines11020370, https://www.mdpi.com/2227-9059/11/2/370
28. Cabinet Paper, Decision to proceed with a booster programme for the COVID-19 Vaccine and Immunisation Programme, https://www.health.govt.nz/system/files/2022-05/decision_to_proceed_with_a_booster_programme_for_the_covid-19_vaccine_and_immunisation_programme.pdf
29. COVID-19 Vaccine Technical Advisory Group, Memo: Priority groups for COVID-19 booster vaccinations: COVID-19 Vaccine Technical Advisory Group (CV TAG) recommendations, 10 November 2021, https://www.tewhatuora.govt.nz/assets/About-us/Who-we-are/Expert-groups/COVID-19-Vaccine-Technical-Advisory-Group-CV-TAG/Recommendations-to-provide-a-booster-vaccination.pdf
30. COVID-19 Public Health Response (Vaccinations) Order 2021, revoked 26 September 2022, https://legislation.govt.nz/regulation/public/2021/0094/latest/LMS487853.html
31. Samik Datta, Giorgia Vattiato, Oliver J. Maclaren, Ning Hua, Andrew Sporle, and Michael J. Plank, ‘The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study’, Vaccine 42, no. 6 (2024), 1383-1391, https://doi.org/10.1016/j.vaccine.2024.01.101, https://pubmed.ncbi.nlm.nih.gov/38307744/
32. Samik Datta, Giorgia Vattiato, Oliver J. Maclaren, Ning Hua, Andrew Sporle, and Michael J. Plank, ‘The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study’, Vaccine 42, no. 6 (2024), 1383-1391, p 1383, https://doi.org/10.1016/j.vaccine.2024.01.101, https://pubmed.ncbi.nlm.nih.gov/38307744/
33. Samik Datta, Giorgia Vattiato, Oliver J. Maclaren, Ning Hua, Andrew Sporle, and Michael J. Plank, ‘The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study’, Vaccine 42, no. 6 (2024), 1383-1391, p 1383, https://doi.org/10.1016/j.vaccine.2024.01.101, https://pubmed.ncbi.nlm.nih.gov/38307744/
34. Michael G. Baker, Amanda Kvalsvig, Michael Plank, Jemma L. Geoghegan, Teresa Wall, Colin Tukuitonga, Jennifer Summers, Julie Bennett, John Kerr, Nikki Turner, Sally Roberts, Kelvin Ward, Bryan Betty, Q. Sue Huang, Nigel French, and Nick Wilson, ‘Continued mitigation needed to minimise the high health burden from COVID-19 in Aotearoa New Zealand’, New Zealand Medical Journal 136, no. 1583 (6 October 2023), 67-91, pp 70-71, https://doi.org/10.26635/6965.6247, https://nzmj.org.nz/journal/vol-136-no-1583/continued-mitigation-needed-to-minimise-the-high-health-burden-from-covid-19-in-aotearoa-new-zealand
35. Michael G. Baker, Amanda Kvalsvig, Michael Plank, Jemma L. Geoghegan, Teresa Wall, Colin Tukuitonga, Jennifer Summers, Julie Bennett, John Kerr, Nikki Turner, Sally Roberts, Kelvin Ward, Bryan Betty, Q. Sue Huang, Nigel French, and Nick Wilson, ‘Continued mitigation needed to minimise the high health burden from COVID-19 in Aotearoa New Zealand’, New Zealand Medical Journal 136, no. 1583 (6 October 2023), 67-91, p 68, https://doi.org/10.26635/6965.6247, https://nzmj.org.nz/journal/vol-136-no-1583/continued-mitigation-needed-to-minimise-the-high-health-burden-from-covid-19-in-aotearoa-new-zealand
36. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), p 8., https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
37. Cabinet Paper, COVID-19 Vaccine and Immunisation Programme – Sequencing Framework Update, 1 March 2021, https://www.health.govt.nz/system/files/2021-05/covid-19_vaccine_and_immunisation_programme_-_sequencing_framework_update.pdf Waitangi Tribunal, Haumaru: The COVID-19 Priority Report (Wellington, 2023), https://forms.justice.govt.nz/search/Documents/WT/wt_DOC_203737436/Haumaru%20W.pdf
38. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
39. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), p 8, https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
40. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), pp 7, 22 and 34, https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
41. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), p 34, https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
42. Health and Disability Commissioner, Information about myocarditis risk from Comirnaty vaccine not clearly highlighted or communicated: Pharmacy Pharmacist, Ms B – A Report by the Health and Disability Commissioner (Case 22HDC02256) (9 April 2024), https://www.hdc.org.nz/decisions/search-decisions/2024/22hdc02256/
43. World Health Organization, ‘COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS): updated statement regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines’, updated 27 October 2021, https://www.who.int/news/item/27-10-2021-gacvs-statement-myocarditis-pericarditis-covid-19-mrna-vaccines-updated
44. Noni E. MacDonald, ‘Vaccine hesitancy: Definition, scope and determinants’, Vaccine 33, no. 34 (17 April 2015 2015), 4161-4164, https://doi.org/10.1016/j.vaccine.2015.04.036, https://www.sciencedirect.com/science/article/pii/S0264410X15005009
45. G Troiano and A Nardi, ‘Vaccine hesitancy in the era of COVID-19’, Public Health 194 (4 March 2021), 245-251, https://doi.org/10.1016/j.puhe.2021.02.025, https://www.sciencedirect.com/science/article/pii/S0033350621000834
European Centre for Disease Prevention and Control, Rollout of COVID-19 vaccines in the EU/EEA: challenges and good practice (Stockholm, 29 March 2021), https://www.ecdc.europa.eu/en/publications-data/rollout-covid-19-vaccines-eueea-challenges-and-good-practice
46. The Disinformation Project, Differential experiences of the pandemic, the infodemic, and information disorders – disinformation impacts for Māori, OIA-2022/23-0915, obtained under Official Information Act 1982 request to Department of the Prime Minister and Cabinet, https://www.dpmc.govt.nz/sites/default/files/2023-09/dpmc-roia-oia-2022-23-0915.pdf
47. Health and Disability Commissioner, Information about myocarditis risk from Comirnaty vaccine not clearly highlighted or communicated: Pharmacy Pharmacist, Ms B – A Report by the Health and Disability Commissioner (Case 22HDC02256) (9 April 2024), https://www.hdc.org.nz/decisions/search-decisions/2024/22hdc02256/
Medsafe, ‘Myocarditis – a potential adverse reaction to Comirnaty (Pfizer COVID-19 vaccine)’, updated 9 June 2021, https://www.medsafe.govt.nz/safety/Alerts/comirnaty-myocarditis.asp
Ministry of Health, ‘Clinicians reminded to be aware of myocarditis and pericarditis symptoms’, media release, 30 August 2021, https://www.health.govt.nz/news/clinicians-reminded-to-be-aware-of-myocarditis-and-pericarditis-symptoms
48. Health and Disability Commissioner, Information about myocarditis risk from Comirnaty vaccine not clearly highlighted or communicated: Pharmacy Pharmacist, Ms B – A Report by the Health and Disability Commissioner (Case 22HDC02256) (9 April 2024), https://www.hdc.org.nz/decisions/search-decisions/2024/22hdc02256/
49. Cabinet Minute, Update on the COVID-19 Immunisation Strategy and Programme, CAB-20-MIN-0509, 7 December 2020, https://www.health.govt.nz/system/files/2021-05/cab-20-min-0509_0.pdf
50. Ministry of Health, COVID-19 Health and Disability System Response Plan (Wellington, 15 April 2020), pp 2, 4-5, https://www.health.govt.nz/publications/covid-19-health-and-disability-system-response-plan
51. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
Cabinet Minute, COVID-19 Vaccine and Immunisation Programme: Sequencing Framework Update, CAB-21-MIN-0040, 1 March 2021, https://www.health.govt.nz/system/files/2021-05/cab-21-min-0040_minute.pdf
52. Ministry of Health, COVID-19 Māori Vaccine and Immunisation Plan: Supplementary to the Updated COVID-19 Māori Health Response Plan (Wellington, 26 March 2021), p 3, https://www.health.govt.nz/publications/covid-19-maori-vaccine-and-immunisation-plan-supplementary-to-the-updated-covid-19-maori-health
53. Ministry of Health, COVID-19 Māori Vaccine and Immunisation Plan: Supplementary to the Updated COVID-19 Māori Health Response Plan (Wellington, 26 March 2021), pp 7-9, https://www.health.govt.nz/publications/covid-19-maori-vaccine-and-immunisation-plan-supplementary-to-the-updated-covid-19-maori-health
54. Samik Datta, Giorgia Vattiato, Oliver J. Maclaren, Ning Hua, Andrew Sporle, and Michael J. Plank, ‘The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study’, Vaccine 42, no. 6 (2024), 1383-1391, https://doi.org/10.1016/j.vaccine.2024.01.101, https://pubmed.ncbi.nlm.nih.gov/38307744/ p 1390.
55. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), p 26, https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
56. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), pp 41-42, https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
57. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), pp 27, 46, https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
58. COVID-19 Vaccine Technical Advisory Group, Memo: Comorbidities associated with poor COVID-19 outcomes for vaccine sequencing considerations: COVID-19 Vaccine Technical Advisory Group (CV TAG) recommendations, 17 March 2021, p 2, https://www.tewhatuora.govt.nz/assets/About-us/Who-we-are/Expert-groups/COVID-19-Vaccine-Technical-Advisory-Group-CV-TAG/comorbidities-associated-with-poor-COVID-19-outcomes-for-vaccine-sequencing-considerations.pdf
In December, they told the Director-General of Health (then considering vaccine eligibility for children) the rollout so far ‘had resulted in inequities for Māori and Pacific adults’. COVID-19 Vaccine Technical Advisory Group, Memo: Decision to use the Pfizer mRNA COVID-19 vaccine for children aged 5-11 years: COVID-19 Vaccine Technical Advisory Group (CV TAG) recommendations, 15 December 2021, https://www.tewhatuora.govt.nz/assets/About-us/Who-we-are/Expert-groups/COVID-19-Vaccine-Technical-Advisory-Group-CV-TAG/Decision-to-use-the-Pfizer-mRNA-COVID-19-vaccine-for-children-aged-5-11-years.pdf
59. Cabinet Paper, COVID-19 Vaccine and Immunisation Programme – Sequencing Framework Update, 1 March 2021, https://www.health.govt.nz/system/files/2021-05/covid-19_vaccine_and_immunisation_programme_-_sequencing_framework_update.pdf
60. Hon Peeni Henare, ‘Significant support goes to Maori and whānau most at risk of COVID-19’, media release, 10 March 2021, https://www.beehive.govt.nz/release/significant-support-goes-maori-and-wh%C4%81nau-most-risk-covid-19
61. Waitangi Tribunal, Haumaru: The COVID-19 Priority Report (Wellington, 2023), pp xv-xvi, https://forms.justice.govt.nz/search/Documents/WT/wt_DOC_203737436/Haumaru%20W.pdf
62. Waitangi Tribunal, Haumaru: The COVID-19 Priority Report (Wellington, 2023), pp 55, xvi, https://forms.justice.govt.nz/search/Documents/WT/wt_DOC_203737436/Haumaru%20W.pdf
63. Department of the Prime Minister and Cabinet, Briefing: Action in response to the Waitangi Tribunal’s Haumaru COVID-19 Priority Report, DPMC-2021/22-1545, 29 April 2022, https://www.dpmc.govt.nz/sites/default/files/2023-01/Briefing-Action-in-response-to-Waitangi-Tribunals-Haumaru-COVID-19-Priority-Report.pdf
64. Kirimatao Paipa (Te Rau Ora), Sarah Hayward (WēBē), Kym Hamilton (Karearea), and Danny Leaoasavaii (The Cause Collective), Review of the equity response to COVID-19: Final report for Ministry of Health, Ministry of Health (July 2022), https://www.health.govt.nz/publications/te-rau-ora-equity-review
65. Waitangi Tribunal, Haumaru: The COVID-19 Priority Report (Wellington, 2023), pp xv-xvi, https://forms.justice.govt.nz/search/Documents/WT/wt_DOC_203737436/Haumaru%20W.pdf
66. The Disinformation Project, Differential experiences of the pandemic, the infodemic, and information disorders – disinformation impacts for Māori, OIA-2022/23-0915, obtained under Official Information Act 1982 request to Department of the Prime Minister and Cabinet, https://www.dpmc.govt.nz/sites/default/files/2023-09/dpmc-roia-oia-2022-23-0915.pdf
67. Te Puni Kōkiri and Te Arawhiti, Briefing: Supporting Māori communities through the COVID-19 transition, 21 October 2021, p 4, https://www.tpk.govt.nz/docs/covid19/tpk-211021-brief-phase1-estab-mccf-2022.pdf
68. Te Puni Kōkiri and Te Arawhiti, Briefing: Supporting Māori communities through the COVID-19 transition, 21 October 2021, p 4, https://www.tpk.govt.nz/docs/covid19/tpk-211021-brief-phase1-estab-mccf-2022.pdf
69. Office of the Auditor-General, Preparations for the nationwide roll-out of the Covid-19 vaccine (May 2021), p 64, https://oag.parliament.nz/2021/vaccines/docs/vaccines-roll-out.pdf
70. Adam Pearse, ‘Covid 19 Delta outbreak: Got ya Dot – Rangatahi Māori driving Auckland vaccination evolution’, The New Zealand Herald, 5 November 2021, https://www.nzherald.co.nz/nz/covid-19-delta-outbreak-got-ya-dot-rangatahi-maori-driving-auckland-vaccination-evolution/2C7BULKHCIX2ZJYEJK6ZEV23HQ/
71. Ministry of Business, Innovation and Employment, New Zealand Foreign Affairs and Trade, and Ministry of Health, Briefing: COVID-19 Vaccine Strategy – Purchasing Strategy and funding envelope, MBIE: 2021-0139, 10 July 2020, pp 4-5, https://covid19.govt.nz/assets/Proactive-Releases/proactive-release-2020-october/HR28-2021-0139-COVID-19-Vaccine-Strategy-Purchasing-Strategy-and-funding-en....pdf
72. Cabinet Paper and Minute, COVID-19 Vaccine Strategy: Early Progress, SWC-20-MIN-0098, 22 July 2020, https://covid19.govt.nz/assets/Proactive-Releases/proactive-release-2020-october/HR40-Minute-and-Cabinet-Paper-COVID-19-vaccine-strategy-early-progress.pdf
73. Cabinet Paper, February 2021 update on the COVID-19 Immunisation Strategy and Programme, 3 February 2021, p 26, https://www.health.govt.nz/system/files/2021-05/february_2021_update_on_the_covid-19_immunisation_strategy_and_programme.pdf
74. Cabinet Paper, February 2021 update on the COVID-19 Immunisation Strategy and Programme, 3 February 2021, p 20, https://www.health.govt.nz/system/files/2021-05/february_2021_update_on_the_covid-19_immunisation_strategy_and_programme.pdf
75. Rt Hon Jacinda Ardern and Hon Chris Hipkins, ‘First batch of COVID-19 vaccine arrives in NZ’, media release, 15 February 2021, https://www.beehive.govt.nz/release/first-batch-covid-19-vaccine-arrives-nz
Ministry of Health, Pfizer agreement, COVID-19 cases, deaths and vaccinations, H202117875, obtained under Official Information Act 1982 request to Ministry of Health, 3 February 2022, https://www.health.govt.nz/system/files/2022-02/h202117875_response.pdf
76. Courts of New Zealand, In the High Court of New Zealand Wellington Registry, Nga Kaitiaki Tuku Iho Medical Action Society Inc v Minister of Health & Ors: Judgment of Ellis J, CIV-2021-485-181 [2021] NZHC 1107 (Wellington, 18 May 2021), https://disasterlaw.ifrc.org/sites/default/files/media/disaster_law/2021-09/1107.pdf
77. Courts of New Zealand, In the High Court of New Zealand Wellington Registry, Nga Kaitiaki Tuku Iho Medical Action Society Inc v Minister of Health & Ors: Judgment of Ellis J, CIV-2021-485-181 [2021] NZHC 1107 (Wellington, 18 May 2021), [70], https://disasterlaw.ifrc.org/sites/default/files/media/disaster_law/2021-09/1107.pdf